Clinical
Trials
Finder
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Search
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Conditions
Steroid-refractory Acute Graft Versus Host Disease
Chengdu, Sichuan
Steroid-refractory Acute Graft Versus Host Disease Clinical Trials in Chengdu, Sichuan
1 recruiting
Chengdu, Sichuan, China
Showing
1–1
of
1
trials
Recruiting
Phase 4
Study of Efficacy and Safety of Ruxolitinib in Patients With Grade II to IV Steroid-refractory Acute Graft vs. Host Disease
Steroid-refractory Acute Graft Versus Host Disease
Novartis Pharmaceuticals
36 enrolled
17 locations
NCT06462469
Feedback